Tomasz Milczek

Prognostic impact of <i>BRCA1</i> pathogenic and <i>BRCA1/BRCA2</i> unclassified variant mutations in patients with ovarian carcinoma

E. Majdak, Jarosław Dębniak, Tomasz Milczek et al. · Cancer · 2005 · 65 citations

Medicine, Genetics, Oncology +17

Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients.

Dagmara Klasa-Mazurkiewicz, Mirosław Jarząb, Tomasz Milczek et al. · PubMed · 2011 · 43 citations

Medicine, Oncology, Pathology +17

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer

Jacek Jan Sznurkowski, Tomasz Milczek, Janusz Emerich · Archives of Gynecology and Obstetrics · 2012 · 29 citations · Full text

Medicine, Oncology, Pathology +17

Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases – preliminary report

E. Majdak, Geertruida H. de Bock, Izabela Brożek et al. · European Journal of Cancer · 2004 · 26 citations

Medicine, Gynecology, Oncology +14

Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients

Dagmara Klasa-Mazurkiewicz, Joanna Narkiewicz, Tomasz Milczek et al. · Gynecologic Oncology · 2009 · 23 citations

Medicine, Cancer Biology, Oncology +12